glucose, (beta-d)-isomer has been researched along with Lung Diseases in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (50.00) | 18.7374 |
| 1990's | 11 (36.67) | 18.2507 |
| 2000's | 2 (6.67) | 29.6817 |
| 2010's | 2 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, J; Doran, AC; Du, J; Gusarova, G; Hook, J; Islam, MN; Kuriakose, G; Proto, JD; Rymond, CC; Sozen, E; Subramanian, M; Tabas, I; Yurdagul, A | 1 |
| Bannenberg, G; Bauman, JG; Devchand, PR; Gronert, K; Guilford, WJ; Moussignac, RL; Parkinson, JF; Perez, HD; Schmidt, BA; Serhan, CN; Subramanyam, B | 1 |
| Abouhamze, A; Efron, PA; Hutchins, B; LaFace, D; McAuliffe, PF; Moldawer, LL; Murday, ME; Scumpia, PO; Tannahill, CL; Ungaro, R | 1 |
| Flick, MR; Goldstein, IM; Horn, JK | 1 |
| Abboud, RT; Elwood, RK; Johnson, AJ; Richter, AM | 1 |
| Finkelstein, MC; Hoffstein, S; Kuhn, SH; Rossouw, DJ | 1 |
| Craddock, PR; Skubitz, KM | 1 |
| Shaw, JO | 1 |
| Klockars, ML; Nordman, SA; Nyberg, PW | 1 |
| Hellewell, PG; Jeffery, PK; Miotla, JM; Williams, TJ | 1 |
| Akaike, T; Ando, M; Hattori, R; Maeda, H; Setoguchi, K; Suga, M; Takahashi, K; Takeya, M | 1 |
| Cook, DN; Kotwal, GJ; Miller, CG | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Zingarelli, B | 1 |
| Campbell, PB | 1 |
| Edwards, JH; Seal, RM; Wagner, JC | 1 |
| Albertine, KH; Gee, MH; Ishihara, Y; McKenna, PJ; Rosolia, DL; Staub, NC | 1 |
| Bruch, J; Hobusch, G; Rehn, B; Zou, T | 1 |
| Borrelli, E; Casini, A; Chiara, O; Giomarelli, PP; Grossi, A; Segala, M | 1 |
| Butterfield, MJ; Dyer, EL; Lefferts, PL; Meyrick, B; Simpson, JF; Snapper, JR | 1 |
| Finley, RR; Mustard, RA; Rutledge, FS; Sharpe, MD; Sibbald, WJ | 1 |
| Hagiwara, T; Horie, T; Koyama, S; Muto, T | 1 |
| Goris, RJ; Schillings, PH; Speekenbrink, RG; van Bebber, IP | 1 |
| Betti, S; Borrelli, E; Chiara, O; Giomarelli, PP; Nespoli, A; Padalino, P | 1 |
| Benestad, HB; Naess, O; Nicolaysen, G; Opdahl, H | 1 |
| Flynn, JT; Gee, MH; Perkowski, SZ; Tahamont, MV; Wasserman, MA | 1 |
| Chensue, SW; Ellul, DA; Higashi, GI; Kunkel, SL; Spengler, M | 1 |
| Choiniere, L; Cooper, JD; Dubois, P; Egan, TM; McDonald, JW; Saunders, NR | 1 |
| Bai, G; Cheng, B; Fang, R; Hou, W; Hou, Y; Jiang, M; Zhou, M | 1 |
| TABONE, D; TABONE, J | 1 |
| Albrecht, CF; Freestone, M; Gouws, L; Kruger, PB; Miller, R; Smit, BJ; van Jaarsveld, PP | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Lung Diseases
| Article | Year |
|---|---|
The pharmacokinetic behaviour of hypoxoside taken orally by patients with lung cancer in a phase I trial.
Topics: Adult; Aged; Alkynes; Antineoplastic Agents; Glucosides; Humans; Lung Diseases; Lung Neoplasms; Middle Aged | 1995 |
29 other study(ies) available for glucose, (beta-d)-isomer and Lung Diseases
| Article | Year |
|---|---|
Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution.
Topics: Animals; Apoptosis; Cell Line; Cells, Cultured; Humans; Inflammation; Interleukin-10; Interleukin-13; Jurkat Cells; Lipopolysaccharides; Lung Diseases; Macrophages; Mice, Inbred C57BL; Mice, Knockout; Peritonitis; Phagocytosis; T-Lymphocytes, Regulatory; Zymosan | 2018 |
Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ear, External; Inflammation; Injections, Intravenous; Lipoxins; Lung Diseases; Male; Mice; Peritonitis; Reperfusion Injury; Zymosan | 2004 |
Dose-dependent improvements in outcome with adenoviral expression of interleukin-10 in a murine model of multisystem organ failure.
Topics: Acute Disease; Adenoviridae; Animals; Bacterial Infections; Dose-Response Relationship, Immunologic; Gene Expression; Gene Targeting; Genetic Therapy; Genetic Vectors; Humans; Immunotherapy, Active; Interleukin-10; Interleukin-6; Lung; Lung Diseases; Mice; Mice, Inbred C57BL; Models, Animal; Multiple Organ Failure; Polysaccharides, Bacterial; Recombinant Fusion Proteins; Survival Rate; Transduction, Genetic; Tumor Necrosis Factor-alpha; Zymosan | 2006 |
Complement and endotoxin-induced lung injury in sheep.
Topics: Animals; Blood; Chemotactic Factors; Chemotaxis, Leukocyte; Complement C5; Complement C5a, des-Arginine; Endotoxins; Escherichia coli; Female; Lung Diseases; Lymph; Neutrophils; Pulmonary Edema; Sheep; Zymosan | 1984 |
Comparison of in vitro neutrophil elastase release in nonsmokers and smokers.
Topics: Adult; Forced Expiratory Flow Rates; Forced Expiratory Volume; Hexosaminidases; Humans; In Vitro Techniques; Lung Diseases; Male; Middle Aged; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Pancreatic Elastase; Respiration; Smoking; Vital Capacity; Zymosan | 1983 |
Biochemical and morphologic changes in rabbit lung following endotracheal instillation of zymosan particles.
Topics: Animals; Disease Models, Animal; Enzyme Activation; Inflammation; Leukocyte Count; Lung Diseases; Macrophage Activation; Phagocytosis; Pulmonary Alveoli; Rabbits; Zymosan | 1983 |
Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg.
Topics: Agranulocytosis; Anaphylatoxins; Cell Aggregation; Chemotaxis, Leukocyte; Complement C5; Complement C5a; Humans; Lung Diseases; Peptide Fragments; Peptides; Receptors, Complement; Renal Dialysis; Zymosan | 1981 |
Leukocytes in chemotactic-fragment-induced lung inflammation. Vascular emigration and alveolar surface migration.
Topics: Animals; Cell Movement; Chemotactic Factors; Female; Leukocytes; Lung Diseases; Male; Microscopy, Electron; Monocytes; Neutrophils; Pulmonary Alveoli; Rabbits; Zymosan | 1980 |
Increased mineral dust-induced production of reactive oxygen species by blood monocytes from patients with malignant diseases.
Topics: Adult; Aged; Asbestos, Serpentine; BCG Vaccine; Cells, Cultured; Dust; Follow-Up Studies; Humans; Luminescent Measurements; Lung Diseases; Lung Neoplasms; Middle Aged; Monocytes; Quartz; Reactive Oxygen Species; Survival Analysis; Zymosan | 1994 |
A role for the beta2 integrin CD11b in mediating experimental lung injury in mice.
Topics: Animals; Antibodies, Monoclonal; Female; Humans; Iodine Radioisotopes; Leukocyte Count; Lipopolysaccharides; Lung Diseases; Macrophage-1 Antigen; Mice; Neutrophils; Serum Albumin; Zymosan | 1996 |
Expression of inducible nitric oxide synthase and its involvement in pulmonary granulomatous inflammation in rats.
Topics: Animals; Enzyme Induction; Granuloma; Intubation, Intratracheal; Isoenzymes; Lung Diseases; Male; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Silicon Dioxide; Zymosan | 1996 |
Two chemotactic factors, C5a and MIP-1alpha, dramatically alter the mortality from zymosan-induced multiple organ dysfunction syndrome (MODS): C5a contributes to MODS while MIP-1alpha has a protective role.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chemokine CCL3; Chemokine CCL4; Chemotactic Factors; Complement C5a; Female; Heart Diseases; Liver Diseases; Lung Diseases; Lymphatic Diseases; Macrophage Inflammatory Proteins; Male; Mice; Mice, Knockout; Multiple Organ Failure; Syndrome; Zymosan | 1996 |
Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat.
Topics: Acute Disease; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Free Radical Scavengers; Ileum; Immunoenzyme Techniques; Intestinal Diseases; Intestinal Mucosa; Liver Diseases; Lung Diseases; Male; Melatonin; Neutrophils; Nitrates; Nitrites; Peritonitis; Peroxidase; Random Allocation; Rats; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Zymosan | 1998 |
Defective leukotaxis in monocytes from patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Chemotaxis, Leukocyte; Chronic Disease; Dose-Response Relationship, Immunologic; Ethambutol; Female; Humans; Immunity, Cellular; In Vitro Techniques; Isoniazid; Lung Diseases; Lymphokines; Male; Middle Aged; Monocytes; Rifampin; Tuberculosis, Pulmonary; Zymosan | 1979 |
Pulmonary responses to particulate materials capable of activating the alternative pathway of complement.
Topics: Animals; Complement System Proteins; Dust; Farmer's Lung; Female; Granuloma; Immunity, Cellular; Leukocytes; Lung Diseases; Macrophages; Male; Phagocytosis; Rabbits; Rats; Respiratory Hypersensitivity; Time Factors; Zymosan | 1976 |
Downregulation of blood and bone marrow neutrophils decreases expression of acute lung injury in sheep.
Topics: Acute Disease; Animals; Blood; Blood Cells; Bone Marrow; Bone Marrow Cells; Fistula; Lung; Lung Diseases; Lymph; Male; Neutrophils; Sheep; Superoxides; Zymosan | 1992 |
Recovery of rat alveolar macrophages by bronchoalveolar lavage under normal and activated conditions.
Topics: Animals; Bronchoalveolar Lavage Fluid; Carbon; Carbon Compounds, Inorganic; Cell Count; Female; Lidocaine; Lung Diseases; Macrophages, Alveolar; Quartz; Rats; Rats, Wistar; Serum Albumin, Bovine; Silicon; Silicon Compounds; Sodium Chloride; Zymosan | 1992 |
Inhibition by methylprednisolone of leukocyte-induced pulmonary damage.
Topics: Animals; Leukocytes; Lipid Peroxidation; Lung; Lung Diseases; Malondialdehyde; Methylprednisolone; Neutrophils; Rabbits; Respiratory Distress Syndrome; Vitamin E; Zymosan | 1991 |
Role of pulmonary inflammation in altered airway responsiveness in three sheep models of acute lung injury.
Topics: Animals; Bronchi; Disease Models, Animal; Endotoxins; Female; Lung; Lung Diseases; Male; Mast Cells; Neutrophils; Plasma; Sheep; Tetradecanoylphorbol Acetate; Zymosan | 1991 |
Failure of therapy with 2,3-dihydroxybenzoic acid to modify the course of sepsis-induced lung injury.
Topics: Animals; Blood; Capillary Permeability; Hydroxybenzoates; Infections; Lung; Lung Diseases; Lymph; Microcirculation; Proteins; Pulmonary Circulation; Sheep; Zymosan | 1990 |
[Effects of antihistamine on acute lung injury caused by activating-complement].
Topics: Acute Disease; Animals; Complement Activation; Complement System Proteins; Diphenhydramine; Histamine Release; Lung Diseases; Rabbits; Zymosan | 1986 |
Endotoxin does not play a key role in the pathogenesis of multiple organ failure. An experimental study.
Topics: Animals; Body Temperature; Body Weight; Endotoxins; Escherichia coli; Hemorrhage; Lung; Lung Diseases; Male; Mice; Mice, Inbred C3H; Multiple Organ Failure; Organ Size; Spleen; Staphylococcus; Zymosan | 1989 |
Leukocyte induced pulmonary damage using intraperitoneal zymosan.
Topics: Animals; Cell Aggregation; Injections, Intraperitoneal; Leukocytes; Lung; Lung Diseases; Malondialdehyde; Multiple Organ Failure; Rabbits; Vitamin E; Zymosan | 1989 |
Pulmonary effects of zymosan activated plasma and phorbol myristate acetate in anaesthetized and awake rabbits.
Topics: Anesthesia; Animals; Complement Activation; Female; Infusions, Intra-Arterial; Lung Diseases; Male; Neutrophils; Rabbits; Tetradecanoylphorbol Acetate; Time Factors; Zymosan | 1988 |
Thromboxane as a mediator of pulmonary dysfunction during intravascular complement activation in sheep.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Capillary Permeability; Complement Activation; Hypertension, Pulmonary; Hypoxia; Imidazoles; Leukocytes; Lung Diseases; Plasma; Pulmonary Circulation; Sheep; Sulfonamides; Thromboxane A2; Zymosan | 1986 |
Dynamics of arachidonic acid metabolism in macrophages from delayed-type hypersensitivity (Schistosoma mansoni egg) and foreign-body-type granulomas.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Female; Foreign-Body Reaction; Granuloma; Hypersensitivity, Delayed; Kinetics; Lung Diseases; Macrophage Activation; Macrophages; Mice; Mice, Inbred CBA; Ovum; Phospholipids; Schistosomiasis mansoni; Zymosan | 1985 |
Contribution of circulating formed elements to prostanoid production in complement-mediated lung injury in sheep.
Topics: Animals; Aspirin; Complement Activation; Cross Circulation; Female; Leukocyte Transfusion; Lung; Lung Diseases; Plasma; Platelet Transfusion; Prostaglandins; Sheep; Thromboxanes; Zymosan | 1985 |
Searching for synergistic bronchodilators and novel therapeutic regimens for chronic lung diseases from a traditional Chinese medicine, Qingfei Xiaoyan Wan.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Asthma; Bronchodilator Agents; Calcium; Cell Line; Chromatography, High Pressure Liquid; Chronic Disease; Disease Models, Animal; Drug Synergism; Drugs, Chinese Herbal; Ephedrine; Flavonoids; Furans; Glucosides; Guinea Pigs; Humans; Lactones; Lignans; Lung Diseases; Medicine, Chinese Traditional; Myocytes, Smooth Muscle; Trachea | 2014 |
[Bio-sterification of glucose. V. Biosynthesis by Bacillus megatherium of the beta-glucoside ester of indolpropionic acid].
Topics: Arthritis; Arthritis, Rheumatoid; Bacillus; Bacillus megaterium; Gluconeogenesis; Glucose; Glucosides; Lung Diseases | 1953 |